Biomedica

SpeeDx Ltd.

12/06/2018

SpeeDx is an Australian-based private company with a portfolio of CE-IVD kits for detection of infectious disease pathogens, sexually transmitted infection (STI), and antimicrobial resistance markers. Proprietary PlexZyme® technology is the driver behind the entire SpeeDx product portfolio.

ResistancePlus MG assay simultaneously detects Mycoplasma genitalium and genetic markers for azithromycin resistance.

For further information, please contact your customer advisor or click the following link.